Clinical Genetic Center, Department of Pediatrics, University of Debrecen, 98 Nagyerdei krt, 4012 Debrecen, Hungary.
Pathol Oncol Res. 2011 Mar;17(1):81-90. doi: 10.1007/s12253-010-9286-2. Epub 2010 Jun 24.
A nationwide study was started in 1993 to provide genetic diagnosis for all newly diagnosed childhood ALL cases in Hungary using cytogenetic examination, DNA-index determination, FISH (aneuploidy, ABL/BCR, TEL/AML1) and molecular genetic tests (ABL/BCR, MLL/AF4, TEL/AML1). Aim of the study was to assess the usefulness of different genetic methods, to study the frequency of various aberrations and their prognostic significance. Results were synthesized for genetic subgrouping of patients. To assess the prognostic value of genetic aberrations overall and event-free survival of genetic subgroups were compared using Kaplan-Meier method. Prognostic role of aberrations was investigated by multivariate analysis (Cox's regression) as well in comparison with other factors (age, sex, major congenital abnormalities, initial WBC, therapy, immunophenotype). Five hundred eighty-eight ALL cases were diagnosed between 1993-2002. Cytogenetic examination was performed in 537 (91%) (success rate 73%), DNA-index in 265 (45%), FISH in 74 (13%), TEL/AML1 RT-PCR in 219 (37%) cases producing genetic diagnosis in 457 patients (78%). Proportion of subgroups with good prognosis in prae-B-cell ALL was lower than expected: hyperdiploidB 18% (73/400), TEL/AML1+ 9% (36/400). Univariate analysis showed significantly better 5-year EFS in TEL/AML1+ (82%) and hyperdiploidB cases (78%) than in tetraploid (44%) or pseudodiploid (52%) subgroups. By multivariate analysis main negative prognostic factors were: congenital abnormalities, high WBC, delay in therapy, specific translocations.
Complementary use of each of genetic methods used is necessary for reliable genetic diagnosis according to the algorithm presented. Specific genetic alterations proved to be of prognostic significance.
1993 年开始了一项全国性研究,旨在通过细胞遗传学检查、DNA 指数测定、FISH(非整倍体、ABL/BCR、TEL/AML1)和分子遗传学检查(ABL/BCR、MLL/AF4、TEL/AML1)为匈牙利所有新诊断的儿童 ALL 病例提供基因诊断。该研究的目的是评估不同遗传方法的有用性,研究各种异常的频率及其预后意义。为患者的遗传亚组分析综合了结果。为了评估遗传异常的总体预后价值和遗传亚组的无事件生存,使用 Kaplan-Meier 方法进行比较。通过多变量分析(Cox 回归)以及与其他因素(年龄、性别、主要先天性异常、初始白细胞计数、治疗、免疫表型)的比较,研究了异常的预后作用。1993-2002 年间诊断出 588 例 ALL 病例。对 537 例(91%)(成功率 73%)进行细胞遗传学检查,对 265 例(45%)进行 DNA 指数测定,对 74 例(13%)进行 FISH,对 219 例(37%)进行 TEL/AML1 RT-PCR,457 例(78%)患者获得基因诊断。前 B 细胞 ALL 中预后良好亚组的比例低于预期:超二倍体 B 为 18%(73/400),TEL/AML1+为 9%(36/400)。单变量分析显示,TEL/AML1+(82%)和超二倍体 B 病例(78%)的 5 年 EFS 明显优于四倍体(44%)或假二倍体(52%)亚组。多变量分析的主要负预后因素是:先天性异常、白细胞计数高、治疗延迟、特定易位。
根据提出的算法,互补使用每种遗传方法对于可靠的基因诊断是必要的。特定的遗传改变被证明具有预后意义。